4.5 Review

Higher versus lower oxygenation strategies in the general intensive care unit population: A systematic review, meta-analysis and meta-regression of randomized controlled trials

Journal

JOURNAL OF CRITICAL CARE
Volume 72, Issue -, Pages -

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.jcrc.2022.154151

Keywords

Oxygen; Intensive care medicine; Hyperoxia; Hypoxia; Mechanical ventilation; Serious adverse events

Ask authors/readers for more resources

This study compared the outcomes of higher and lower oxygen strategies in adult ICU patients and found no significant differences in 90-day mortality, support free days, and ICU and hospital length of stay. However, a lower incidence of serious adverse events was observed in the lower oxygen group.
Purpose: Oxygen therapy is vital in adult intensive care unit (ICU) patients, but it is indistinct whether higher or lower oxygen targets are favorable. Our aim was to update the findings of randomized controlled trials (RTCs) comparing higher and lower oxygen strategies.Materials and methods: MEDLINE, EMBASE, and Web of Science were searched. RCTs comparing higher (liberal, hyperoxia) and lower (conservative, normoxia) oxygen in adult mechanically ventilated ICU patients were in-cluded. The main outcome was 90-day mortality; other outcomes include serious adverse events (SAE), support free days and length of stay (LOS).Results: No significant difference was observed for 90-day mortality. A lower incidence was found for SAEs, favor-ing lower oxygenation (OR, 0.86; 95%CI, 0.77-0.96; I 2 13%). No differences were observed in either support free days at day 28 or ICU and hospital LOS. Conclusions: No difference was found for 90-day mortality, support free days and ICU and hospital LOS. However, a lower incidence of SAEs was found for lower oxygenation. These findings may have clinical implications for practice guidelines, yet it remains of paramount importance to continue conducting clinical trials, comparing groups with a clinically relevant contrast and focusing on the impact of important side effects.(c) 2022 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available